Soumya Eswaran
Mon, Apr 28, 2025, 5:40 AM 3 min read
In This Article:
White Falcon Capital Management, an concern money manager, released its first-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The fund’s show for the caller 4th was beneath expectations, arsenic the gains from golden and metallic royalty holdings were incapable to screen the losses successful immoderate of the larger positions. On a affirmative note, the portfolio company, Converge Technologies (CTS), was acquired astatine a important premium during this time. In the quarter, the money returned -6.7% compared to a -4.4% instrumentality for the S&P 500 (CAD), -1.2 % for the MSCI All Country (CAD), and 1.5% for the S&P TSX TR. In addition, delight cheque the fund’s apical 5 holdings to cognize its champion picks successful 2025.
In its first-quarter 2025 capitalist letter, White Falcon Capital Management highlighted stocks specified arsenic Grifols, S.A. (NASDAQ:GRFS). Grifols, S.A. (NASDAQ:GRFS) is simply a plasma therapeutic company. The one-month instrumentality of Grifols, S.A. (NASDAQ:GRFS) was 1.41%, and its shares gained 11.27% of their worth implicit the past 3 months. On April 25, 2025, Grifols, S.A. (NASDAQ:GRFS) banal closed astatine $7.21 per stock with a marketplace capitalization of $5.914 billion.
White Falcon Capital Management stated the pursuing regarding Grifols, S.A. (NASDAQ:GRFS) successful its Q1 2025 capitalist letter:
"In the appendix of this letter, you volition find our concern thesis connected Grifols, S.A. (NASDAQ:GRFS), a family-owned Spanish multinational and a starring subordinate successful the oligopolistic plasma-derived therapies market. Years of mismanagement and mediocre firm governance, exacerbated by COVID-19 challenges and precocious debt, person weighed connected its performance. However, we present spot the concern inflecting owed to an operational betterment program implemented by a caller absorption team. Sid Kapur, an concern expert intern with White Falcon, authored this report. He has been instrumental successful supporting our probe efforts and has played a cardinal relation successful moving galore files forward.
A state-of-the-art manufacturing facility, with robotic arms and conveyor belts for cause production.
Grifols, S.A. (NASDAQ:GRFS) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. As per our database, 15 hedge money portfolios held Grifols, S.A. (NASDAQ:GRFS) astatine the extremity of the 4th quarter, compared to 19 successful the 3rd quarter. While we admit the imaginable of Grifols, S.A. (NASDAQ:GRFS) arsenic an investment, our condemnation lies successful the content that AI stocks clasp greater committedness for delivering higher returns, and doing truthful wrong a shorter timeframe. If you are looking for an AI banal that is arsenic promising arsenic NVIDIA but that trades astatine little than 5 times its earnings, cheque retired our study astir the cheapest AI stock.